Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Cervical Cancer

  Free Subscription


22.06.2026

1 Acad Pathol
1 Adv Radiat Oncol
2 Am J Obstet Gynecol
1 Anal Cell Pathol (Amst)
1 Anal Methods
1 Ann Afr Med
1 Arch Gynecol Obstet
1 BMC Cancer
1 BMC Prim Care
2 BMC Womens Health
1 BMJ
1 BMJ Open
1 Br J Cancer
1 Cancer Biother Radiopharm
1 Cancer Imaging
1 Cancer Manag Res
1 Cancer Nurs
1 Cancer Rep (Hoboken)
1 Cell Biochem Biophys
1 Cell Signal
1 Chempluschem
1 Clin Lab
1 Curr Aging Sci
1 Ecotoxicol Environ Saf
1 Enferm Infecc Microbiol Clin (Engl Ed)
1 Eur J Cancer Prev
1 Eur J Surg Oncol
1 Expert Rev Pharmacoecon Outcomes Res
1 FASEB J
2 Front Immunol
4 Front Oncol
1 Front Public Health
1 Front Surg
1 Gulf J Oncolog
1 Hereditas
1 Hum Vaccin Immunother
1 Int Immunopharmacol
1 Int J Clin Oncol
1 Int J Gynaecol Obstet
2 Int J Gynecol Pathol
2 Int J Womens Health
1 iScience
1 J Acquir Immune Defic Syndr
1 J Addict Med
1 J Community Health
2 J Gynecol Obstet Hum Reprod
1 J Health Commun
1 J Infect
1 J Int Assoc Provid AIDS Care
1 J Med Imaging Radiat Sci
1 J Med Radiat Sci
1 J Med Virol
2 J Obstet Gynaecol Res
1 J Pathol Clin Res
1 J Transl Med
1 Jpn J Clin Oncol
1 Kathmandu Univ Med J (KUMJ)
1 Lab Invest
2 Lancet
1 mBio
1 Med Image Anal
1 Microbiol Spectr
1 Mol Biol Rep
1 Mol Genet Genomics
1 OMICS
1 Oncol Lett
5 Photodiagnosis Photodyn Ther
1 PLOS Glob Public Health
5 PLoS One
1 Public Health
4 Sci Rep
1 Sex Med
1 Soc Sci Med
1 Surg Oncol
4 Transl Cancer Res
1 Transl Oncol
1 Urology
1 Virchows Arch
1 Virus Res


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Acad Pathol

  1. BUNDUKI GK
    Beyond H uman papillomavirus (HPV): why female genital schistosomiasis must be addressed in Africa's cervical cancer prevention agenda.
    Acad Pathol. 2026;13:100274.
    PubMed         Abstract available


    Adv Radiat Oncol

  2. SHINGHAL A, Sanyal S, Pradhan S, Kapoor AR, et al
    Validation of IBS-GEC ESTRO-ABS Computed Tomography-Based Contouring Recommendations Using Prebrachytherapy Magnetic Resonance Imaging in Patients With Cervical Cancer Treated With Definitive Radiation Therapy.
    Adv Radiat Oncol. 2026;11:102044.
    PubMed         Abstract available


    Am J Obstet Gynecol

  3. LEVIN G, Gilbert L, Pareja R, Fumagalli D, et al
    Trachelectomy in decline: national trends, outcomes, and academic output across 3 major databases.
    Am J Obstet Gynecol. 2026;235:123-131.
    PubMed         Abstract available

  4. EERO N, Aarno L, Qiang K, Veronika F, et al
    Genotype and Age Shape the Risk of Persistent High-Risk HPV Infections.
    Am J Obstet Gynecol. 2026 Feb 25:S0002-9378(26)00121.
    PubMed         Abstract available


    Anal Cell Pathol (Amst)

  5. SERTEL E
    Diagnostic Accuracy Rate of Tertiary Center Colposcopy Unit.
    Anal Cell Pathol (Amst). 2026;2026:e9307280.
    PubMed         Abstract available


    Anal Methods

  6. YANG Y, He H, Lu R, Li Y, et al
    Fluorescence-colorimetric dual-mode detection of cysteine in artificial urine with potential relevance to cervical cancer.
    Anal Methods. 2026 Jun 10. doi: 10.1039/d6ay00473.
    PubMed         Abstract available


    Ann Afr Med

  7. VERMA N, Singh V
    Blood-based Biomarkers in Cervical Cancer: The Emerging Role of Circulating Human Papillomavirus and Tumor Deoxyribonucleic Acid.
    Ann Afr Med. 2026 Jun 19. doi: 10.4103.
    PubMed         Abstract available


    Arch Gynecol Obstet

  8. STALP JL, Schneider JA, Steinkasserer L, Hachenberg J, et al
    Comparing clinical decision-making between colposcopists and large language models in cervical dysplasia management: a pilot prospective multicenter study.
    Arch Gynecol Obstet. 2026;313:206.
    PubMed         Abstract available


    BMC Cancer

  9. ADEBISI TM, Oluwasola TAO, Ndikom CM, Salako BL, et al
    Feasibility of the effectiveness of a psychoeducational intervention on the physical and psychosexual functioning of women being treated for cervical cancer in a tertiary hospital in Southwest, Nigeria: a quasi-experimental study.
    BMC Cancer. 2026 Jun 15. doi: 10.1186/s12885-026-16288.
    PubMed         Abstract available


    BMC Prim Care

  10. CHALLGUA CH, Rodriguez DE, Goicolea I, Linander I, et al
    Barriers and facilitators in access to cervical cancer secondary prevention in Cochabamba, Bolivia: a qualitative study of healthcare providers' perceptions.
    BMC Prim Care. 2026;27:233.
    PubMed         Abstract available


    BMC Womens Health

  11. AYENI OA, Mmereki D, Mistry H, Achilonu O, et al
    Disease characteristics, treatment, and overall survival outcomes of patients with locally advanced cervical cancer referred for radiation therapy in Johannesburg, South Africa: a 2-year retrospective study.
    BMC Womens Health. 2026 Jun 17. doi: 10.1186/s12905-026-04611.
    PubMed         Abstract available

  12. BEVILACQUA F, Robba E, Berchialla P, Preti M, et al
    Psychological distress and dyadic trust in Italian women awaiting colposcopy after positive cervical cancer screening: a cross-sectional study.
    BMC Womens Health. 2026 Jun 15. doi: 10.1186/s12905-026-04500.
    PubMed         Abstract available


    BMJ

  13. SASIENI P, Rix J
    Vaccination is helping to eliminate cervical cancer in several countries, and continued surveillance is essential.
    BMJ. 2026;393:e304038.
    PubMed        


    BMJ Open

  14. KANKARIA A, Shukla P, Vijayakumar M, Sachdeva A, et al
    Enhancing screening, early diagnosis and treatment initiation of oral, breast and cervical cancer in selected districts of India: an implementation research protocol.
    BMJ Open. 2026;16:e112428.
    PubMed         Abstract available


    Br J Cancer

  15. ELLIS LB, Bowden SJ, Paraskevaidi M, Lyons D, et al
    Methylation biomarkers in non-regressive cervical intraepithelial neoplasia grade 2 lesions: an epigenome wide association study.
    Br J Cancer. 2026;135:118-126.
    PubMed         Abstract available


    Cancer Biother Radiopharm

  16. CI J, Wang C, Wang Y, Li D, et al
    MICA/MICB-Mediated NKG2D Immune Escape in Cervical Cancer: Single-Cell Transcriptomic Mapping of Radionuclide Therapy Targets for Precision Radioimmunotherapy.
    Cancer Biother Radiopharm. 2026 Jun 13:10849785261458459.
    PubMed         Abstract available


    Cancer Imaging

  17. TAN S, Liu X, Li B, Bao T, et al
    Node-RADS in cervical cancer: a multi-reader agreement and diagnostic performance study.
    Cancer Imaging. 2026 Jun 17. doi: 10.1186/s40644-026-01072.
    PubMed         Abstract available


    Cancer Manag Res

  18. LIU L, Zhang Q, Liu L, Wu Z, et al
    Development and Validation of a Nomogram Integrating Body Composition and Inflammatory Markers to Predict Concurrent Chemoradiotherapy Response in Locally Advanced Cervical Cancer.
    Cancer Manag Res. 2026;18:600310.
    PubMed         Abstract available


    Cancer Nurs

  19. AKINCI G, Aydin R
    The Effect of Women's Perceptions of Their Nurses' Communication on Their Distress and Fear of Cancer During Colposcopy: A Multicenter Study.
    Cancer Nurs. 2026;49:E352-E360.
    PubMed         Abstract available


    Cancer Rep (Hoboken)

  20. SCHOLL S, Nery ED, Gestraud P, Halladjian M, et al
    Unveiling Candidate Markers for Drug Resistance or Synthetic Lethality in Cervical Cancer: Integrative Analysis of Genetic and Pharmacoprofiling.
    Cancer Rep (Hoboken). 2026;9:e70599.
    PubMed         Abstract available


    Cell Biochem Biophys

  21. SANGER G, Damongilala LJ, Lau V, Romano R, et al
    Cytotoxic Activity of Halymenia durvillaei against Cervical Cancer Cells: In Vitro and Computational Evidence.
    Cell Biochem Biophys. 2026 Jun 17. doi: 10.1007/s12013-026-02099.
    PubMed         Abstract available


    Cell Signal

  22. ZHENG S, Shao F, Shao L, Zhang L, et al
    FHIT suppresses cervical squamous cell carcinoma progression by negatively regulating UBE2I-mediated SUMO modification of NOTCH1.
    Cell Signal. 2026;145:112582.
    PubMed         Abstract available


    Chempluschem

  23. FU H, Shakeel RS, Peng YB, Liu J, et al
    Cinoplatin: An Efficient Platinum(IV) Prodrug Effective in Inhibiting the Growth of Cervical Cancer.
    Chempluschem. 2026;91:e70191.
    PubMed         Abstract available


    Clin Lab

  24. SHAN W, Shan Q, Xu X, Chen J, et al
    A Machine Learning Framework for Predicting Nosocomial Escherichia coli Infections in Cervical Cancer.
    Clin Lab. 2026;72.
    PubMed         Abstract available


    Curr Aging Sci

  25. RATHOD G, Swetha S, Nalini B
    Cervical Cancer Screening in Elderly Women: Impact of Aging on Cytology and the Role of HPV Testing.
    Curr Aging Sci. 2026 Jun 11. doi: 10.2174/0118746098435866260603051645.
    PubMed         Abstract available


    Ecotoxicol Environ Saf

  26. LIU F, Sun W, Ding B, Yu B, et al
    Association between exposure to perfluoroalkyl ether sulfonate F-53B and cervical cancer risk and its mechanisms of cervical toxicity in Chinese women.
    Ecotoxicol Environ Saf. 2026;320:120373.
    PubMed         Abstract available


    Enferm Infecc Microbiol Clin (Engl Ed)

  27. GONZALEZ CANTO J, Burgos Teruel A, Burgos Isern MA
    Prevalence and characteristics of HPV infection in the prevaccination and pre-screening era (2012-2022) in the Valencian Community.
    Enferm Infecc Microbiol Clin (Engl Ed). 2026;44:503174.
    PubMed         Abstract available


    Eur J Cancer Prev

  28. HALLIK R, Innos K, Janes J, Karro H, et al
    Sociodemographic factors predicting preference for human papillomavirus self-sampling in cervical cancer screening: comparison of opt-out and opt-in strategies.
    Eur J Cancer Prev. 2026 Jun 16. doi: 10.1097/CEJ.0000000000001028.
    PubMed         Abstract available


    Eur J Surg Oncol

  29. BIZZARRI N, Schivardi G, Casarin J, Di Martino G, et al
    The incidence of low volume metastases according to Silva pattern in cervical adenocarcinoma undergoing sentinel lymph node biopsy.
    Eur J Surg Oncol. 2026;52:111875.
    PubMed         Abstract available


    Expert Rev Pharmacoecon Outcomes Res

  30. ZHOU J, Cai J, Zhang L, Zhu Y, et al
    Effectiveness and cost-effectiveness of pembrolizumab in persistent, recurrent, or metastatic cervical cancer with PD-L1 CPS 1-10: secondary analysis of KEYNOTE-826 using innovative KMSubtraction.
    Expert Rev Pharmacoecon Outcomes Res. 2026.
    PubMed         Abstract available


    FASEB J

  31. PANG H, Zhu S, Lu Q, Zheng W, et al
    LAT1 Promotes Immunosuppression in Cervical Cancer by Interacting With TRIM67 to Facilitate IRF3 Ubiquitination and Degradation.
    FASEB J. 2026;40:e72041.
    PubMed         Abstract available


    Front Immunol

  32. YAO H, Hao Z, Zhang X, Liu S, et al
    Severe immune checkpoint inhibitor-induced 3M syndrome: a case report.
    Front Immunol. 2026;17:1840526.
    PubMed         Abstract available

  33. LI Y, Zhang J, Wu S, Liu Z, et al
    The impact of gut microbiota on cervical cancer and precancerous lesions: neglected status, mechanisms, challenges, and a call to action.
    Front Immunol. 2026;17:1826283.
    PubMed         Abstract available


    Front Oncol

  34. XU Z, Xu J, Gu Y, Ji Y, et al
    Systematic review of self-management practices for vaginal irrigation among cervical cancer patients undergoing radiotherapy.
    Front Oncol. 2026;16:1807898.
    PubMed         Abstract available

  35. ZHANG L, Fu H, Feng Y, Tian J, et al
    Preliminary construction and validation of a prognostic prediction model for cervical cancer based on tumor mechanics-related genes.
    Front Oncol. 2026;16:1841456.
    PubMed         Abstract available

  36. KAMEPALLI S, Chavana A, Ludwig M, Flanagan M, et al
    Chemoradiation after chemotherapy for metastatic cervical cancer can provide chemo-free time.
    Front Oncol. 2026;16:1826017.
    PubMed         Abstract available

  37. HAO F, Cheng X, He J, Song S, et al
    A bibliometric analysis and visualization of trends in cervical cancer screening technologies based on dual-database analysis.
    Front Oncol. 2026;16:1829800.
    PubMed         Abstract available


    Front Public Health

  38. OLUBAYO GT, Bakare A, Salako J, Olufayo OE, et al
    Early implementation and contextual determinants of the human papillomavirus vaccine rollout and uptake in Nigeria: a mixed-methods study.
    Front Public Health. 2026;14:1834756.
    PubMed         Abstract available


    Front Surg

  39. TAN H, Yang X
    Effect of aesthetic nursing interventions on the health-related quality of life of cervical cancer patients after treatment.
    Front Surg. 2026;13:1609977.
    PubMed         Abstract available


    Gulf J Oncolog

  40. PASHA T, Radhakrishna N, Buchapudi RR, Pullan SS, et al
    Impact of size of ovoids with Intra-cavitary Brachytherapy on dose to point A in patients with Cancer Cervix.
    Gulf J Oncolog. 2025;1:28-34.
    PubMed         Abstract available


    Hereditas

  41. YIN Y, Huang Y, Lin L, Cui M, et al
    The role of miR-557 in modulating cervical cancer malignancy by targeting TAOK1.
    Hereditas. 2026 Jun 12. doi: 10.1186/s41065-026-00695.
    PubMed         Abstract available


    Hum Vaccin Immunother

  42. BIERRENBACH AL, Pungartnik PC, Goncalves Queijo R, Rego JG, et al
    Early effects of HPV vaccination on high-grade cervical intraepithelial neoplasia in Brazil: Evidence from outpatient data.
    Hum Vaccin Immunother. 2026;22:2684304.
    PubMed         Abstract available


    Int Immunopharmacol

  43. FEI Y, Mao Y, Cai W, Huang L, et al
    Targeting cellular senescence in cervical Cancer: a novel pathway to preserve reproductive potential.
    Int Immunopharmacol. 2026;185:117005.
    PubMed         Abstract available


    Int J Clin Oncol

  44. HAMADA K, Umemiya M, Yamanoi K, Fukunishi T, et al
    Nationwide trends in surgery selection and minimally invasive surgery for cervical cancer with preoperative T1B1/T1B2 disease in Japan.
    Int J Clin Oncol. 2026 Jun 12. doi: 10.1007/s10147-026-03095.
    PubMed         Abstract available


    Int J Gynaecol Obstet

  45. DORJI N, Dorjey Y, Tshering S, Bhujel D, et al
    Status of human papillomavirus infection after loop electrosurgical excision procedure at the National Referral Hospital, Bhutan, 2022-2023: A retrospective study.
    Int J Gynaecol Obstet. 2026;174:145-151.
    PubMed         Abstract available


    Int J Gynecol Pathol

  46. PSILOPATIS I, Vrettou K
    Diagnostic Proficiency of Large Language Models in the Interpretation of Cervical Cytopathology.
    Int J Gynecol Pathol. 2026;45:297-303.
    PubMed         Abstract available

  47. BAHMAD HF, Alloush F, Jaspe G, Abulaban A, et al
    PRAME Immunohistochemical Expression as a Diagnostic Tool to Distinguish Between Endocervical and Endometrial Adenocarcinomas.
    Int J Gynecol Pathol. 2026;45:274-284.
    PubMed         Abstract available


    Int J Womens Health

  48. ZUBAIDAH T
    A Longitudinal Qualitative Study on the Perioperative Symptom-Demand Journey Map of Patients with Cervical Cancer [Letter].
    Int J Womens Health. 2026;18:628657.
    PubMed        

  49. SOLEHATI T, Haroen H, Hazmi HB, Putri YHS, et al
    Telehealth Pathways for Cervical Cancer Prevention: A Scoping Review of Strategies to Close the Screening Gap.
    Int J Womens Health. 2026;18:590474.
    PubMed         Abstract available


    iScience

  50. OLWAL CO, Rathore U, Makanani SK, Kaushal P, et al
    Paracrine signals from HIV-1-infected immune cells reprogram cervical cancer pathways.
    iScience. 2026;29:116083.
    PubMed         Abstract available


    J Acquir Immune Defic Syndr

  51. NICOLLS S, McClymont E, Lee M, Coutlee F, et al
    Incidence and Prevalence of Human Papillomavirus Infection to Predict Outcomes from HPV-Based Cervical Cancer Screening in Women and People with a Cervix Living with HIV.
    J Acquir Immune Defic Syndr. 2026 Jun 5. doi: 10.1097/QAI.0000000000003902.
    PubMed         Abstract available


    J Addict Med

  52. THOMSON M, Tessier KM, Jones C, Lim N, et al
    Prevalence of Alcohol Use Disorder and Alcohol-related Liver Disease in Women Undergoing Cervical Cancer Screening: A Missed Opportunity to Screen?
    J Addict Med. 2026 Jun 19. doi: 10.1097/ADM.0000000000001705.
    PubMed         Abstract available


    J Community Health

  53. MORICE M, Cedric MA, Mushendwa JA, Gulamhussein MA, et al
    Human Papillomavirus Vaccine Uptake and its Determinants among Parents of Adolescent Girls in Tanga city, Tanzania.
    J Community Health. 2026;51:378-385.
    PubMed         Abstract available


    J Gynecol Obstet Hum Reprod

  54. YACOUB N, Domizio ND, Ramanah R, Lepiller Q, et al
    Prevalence and distribution of high-risk HPV in an organized hospital-based cervical cancer screening cohort.
    J Gynecol Obstet Hum Reprod. 2026;55:103231.
    PubMed         Abstract available

  55. MARTINEZ F, Durand C, Morel Z, Zanoune AD, et al
    Organized cervical cancer screening in Brittany: follow-up at 1 year after a positive virological test with normal cytology.
    J Gynecol Obstet Hum Reprod. 2026 Jun 12:103229.
    PubMed         Abstract available


    J Health Commun

  56. YAO S, Liu J, Dalisay F, Johnson BK, et al
    Cervical Cancer Information Seeking in the Digital Communication Environment.
    J Health Commun. 2026 Jun 15:1-11. doi: 10.1080/10810730.2026.2689090.
    PubMed         Abstract available


    J Infect

  57. GAO D, Wang X, Juan J, Bi H, et al
    Prevalence and genotype distribution of cervical human papillomaviruses infection across cytology: A nationwide, cross-sectional study of over 1 million Chinese women from 2020 to 2024.
    J Infect. 2026;93:106773.
    PubMed         Abstract available


    J Int Assoc Provid AIDS Care

  58. FEREDE YA, Zeleke AM, Tassew WC, Abebe AD, et al
    Cervical Cancer Screening Utilization and Its Associated Factors Among Women Living With HIV in Public Health Facilities of Gondar Town, Northwest Ethiopia.
    J Int Assoc Provid AIDS Care. 2026;25:23259582261460521.
    PubMed         Abstract available


    J Med Imaging Radiat Sci

  59. ANDREE-EVARTS D, Carroll S, Osborne C, Clarke Z, et al
    Case study: Innovative collaboration to connect Aboriginal women from rural New South Wales to world-class cancer treatment for cervical cancer.
    J Med Imaging Radiat Sci. 2026;57:102449.
    PubMed         Abstract available


    J Med Radiat Sci

  60. WEI W, Ku D, Rutherford N
    Prognostic Value of Combined FDG PET and MRI Analysis of Cervical Cancer: A Systematic Review and Meta-Analysis.
    J Med Radiat Sci. 2026 Jun 18. doi: 10.1002/jmrs.70103.
    PubMed         Abstract available


    J Med Virol

  61. LATSUZBAIA A, Keer SV, Broeck DV, Weyers S, et al
    Accuracy of Allplex HPV HR Detection Full Genotyping Assay on Cervical Samples Compared to Vaginal Self-Samples.
    J Med Virol. 2026;98:e70982.
    PubMed         Abstract available


    J Obstet Gynaecol Res

  62. OUCHI H, Chiyoda T, Sakai K, Shiraishi Y, et al
    Para-Aortic Lymph Node Metastasis Detected by Sentinel Lymph Node Biopsy in Cervical Cancer Initially Presumed to be Stage IA2: A Case Report.
    J Obstet Gynaecol Res. 2026;52:e70377.
    PubMed         Abstract available

  63. FUJITA T, Hyuga S, Adachi M, Onishi Y, et al
    Maternal Hemodynamic Management Using the FloTrac Monitor During Ex Utero Intrapartum Treatment for a Giant Fetal Cervical Mass: A Case Report.
    J Obstet Gynaecol Res. 2026;52:e70368.
    PubMed         Abstract available


    J Pathol Clin Res

  64. LIU W, Wang XJ, Cui YM, Liu JC, et al
    Clinicopathological and molecular characterization of HPV-associated cervical poorly cohesive carcinoma: a rare aggressive entity.
    J Pathol Clin Res. 2026;12:e70100.
    PubMed         Abstract available


    J Transl Med

  65. XIN R, Gong M, Guo J, Tian J, et al
    Cervical cancer screening policy inequality worldwide: a systematic review of disparities in access and implementation.
    J Transl Med. 2026 Jun 13. doi: 10.1186/s12967-026-08460.
    PubMed         Abstract available


    Jpn J Clin Oncol

  66. FUSEGI A, Nishikawa K, Kon T, Kamata M, et al
    Surgical de-escalation in early-stage cervical cancer: current evidence and future perspectives.
    Jpn J Clin Oncol. 2026 Jun 12:hyag092. doi: 10.1093.
    PubMed         Abstract available


    Kathmandu Univ Med J (KUMJ)

  67. SHAKYA S, Paneru B, Uprety S, Acharya Y, et al
    Acceptability of Self-sampling in Human Papillomavirus Deoxyribonucleic acid based Cervical Screening in Nepal: A Mixed-Methods Study.
    Kathmandu Univ Med J (KUMJ). 2025;23:433-440.
    PubMed         Abstract available


    Lab Invest

  68. ZHANG G, Yang B
    Progressive Activation of YAP1 in Human Papillomavirus-Associated Squamous Intraepithelial Lesions and Squamous Cell Carcinoma.
    Lab Invest. 2026;106:106127.
    PubMed         Abstract available


    Lancet

  69. PORTNOY A, Burger EA
    HPV vaccination and early declines in cervical cancer deaths.
    Lancet. 2026 Jun 17:S0140-6736(26)01024-X. doi: 10.1016/S0140-6736(26)01024.
    PubMed        

  70. SASIENI P, Falcaro M
    Cervical cancer mortality trends following HPV vaccination in England, 2001-24: an analysis of population-based mortality data.
    Lancet. 2026 Jun 17:S0140-6736(26)00918-9. doi: 10.1016/S0140-6736(26)00918.
    PubMed         Abstract available


    mBio

  71. ZHANG T, Qian Q, Zhen Q, Zhang J, et al
    Prevotella bivia promotes cervical cancer progression and modulates macrophage polarization, while Lactobacillus iners suppresses these processes: evidence from multiomics analysis.
    mBio. 2026 Jun 15:e0037426. doi: 10.1128/mbio.00374.
    PubMed         Abstract available


    Med Image Anal

  72. FAN L, Sowmya A, Meijering E, Yu Z, et al
    Medical hierarchical image classification via dual-geometry image-text learning.
    Med Image Anal. 2026;112:104120.
    PubMed         Abstract available


    Microbiol Spectr

  73. SAINI V, Guo Z, Yu J, Wu D, et al
    Development of a novel, urine-based high-risk human papillomavirus polymerase chain reaction test to predict cervical intraepithelial neoplasia abnormalities associated with cervical cancer.
    Microbiol Spectr. 2026 Jun 17:e0379625. doi: 10.1128/spectrum.03796.
    PubMed         Abstract available


    Mol Biol Rep

  74. WU Z, Lan D, He C, Li N, et al
    IGFL2-AS1 is associated with poor prognosis in cervical cancer and promotes disease progression via the miR-126-5p/MACC1 axis.
    Mol Biol Rep. 2026;53:970.
    PubMed         Abstract available


    Mol Genet Genomics

  75. TAN WM, Wang JQ, Li L, Liu XJ, et al
    miR-133b induces antitumor immunity in cervical cancer through modulating CMTM6/PD-L1 axis.
    Mol Genet Genomics. 2026;301:140.
    PubMed         Abstract available


    OMICS

  76. SAJWANI N, Suchitha GP, Prasad TSK, Dagamajalu S, et al
    Procaterol Enhances Cisplatin-Induced Cytotoxicity via Apoptosis, Oxidative Stress, and Cell Cycle Arrest in Breast and Cervical Cancer Cells.
    OMICS. 2026 Jun 19:15578100261459475. doi: 10.1177/15578100261459475.
    PubMed         Abstract available


    Oncol Lett

  77. KONG Y, Zhu L, Xiao Y
    Warm autoimmune hemolytic anemia following definitive chemoradiotherapy for cervical cancer: A case report.
    Oncol Lett. 2026;32:327.
    PubMed         Abstract available


    Photodiagnosis Photodyn Ther

  78. LUO M, Wu J, Duan Z, Zhou D, et al
    Analysis of factors affecting lesion or HPV clearance rate after photodynamic therapy of persistent cervical intraepithelial neoplasia grade 1.
    Photodiagnosis Photodyn Ther. 2026;59:105491.
    PubMed         Abstract available

  79. QI W, Ma L, Cui S, Huang Z, et al
    Evaluation of photodynamic therapy (PDT) of high-risk cervical low-grade squamous intraepithelial lesions (LSIL) - A single center experience.
    Photodiagnosis Photodyn Ther. 2026;59:105490.
    PubMed         Abstract available

  80. CHEN Y, Liu L, Chen Y, Wang Y, et al
    Prognostic factors influencing the cure rate of 5-Aminolevulinic acid photodynamic therapy (ALA-PDT) of High-grade squamous intraepithelial lesions (HSIL): A retrospective cohort study.
    Photodiagnosis Photodyn Ther. 2026;59:105463.
    PubMed         Abstract available

  81. CHEN M, Li H, Wang L, Li L, et al
    Evaluation of the efficacy and safety of photodynamic therapy after laser pretreatment for treating cervical high-grade intraepithlial lesions in patients of childbearing age: a non-randomized controlled prospective study.
    Photodiagnosis Photodyn Ther. 2026;59:105451.
    PubMed         Abstract available

  82. WANG Y, Shi Q, Zhou X, Qiu L, et al
    A meta-analysis of photodynamic therapy in the treatment of cervical intraepithelial neoplasia: Based on randomized controlled trials.
    Photodiagnosis Photodyn Ther. 2026;59:105408.
    PubMed         Abstract available


    PLOS Glob Public Health

  83. OLUBODUN T, Luoga P, Adam J
    Prevalence and determinants of cervical cancer screening among women aged 30-49 years in Nigeria: A population-based cross-sectional study.
    PLOS Glob Public Health. 2026;6:e0006668.
    PubMed         Abstract available


    PLoS One

  84. EZECHUKWU C, Ayandipo EO, Osoteku D, Ibrahim R, et al
    Gaps and barriers preventing sustained delivery of HPV vaccination in Kano, Kaduna, and Lagos states: An exploratory qualitative study.
    PLoS One. 2026;21:e0350510.
    PubMed         Abstract available

  85. MUHAMMAD-OLODO AO, Asher L
    Understanding factors influencing HPV vaccine uptake among caregivers in Kwara State, Nigeria: A qualitative study.
    PLoS One. 2026;21:e0351659.
    PubMed         Abstract available

  86. NOREEN K, Noor M, Maryam S, Baig M, et al
    From global to local: Developing a context-specific BeSD-HPV tool through cultural and linguistic adaptation in Pakistan.
    PLoS One. 2026;21:e0350162.
    PubMed         Abstract available

  87. ILGAZI KILIC E, Kilic S
    Multi-scale feature integration with enhanced cytomorph for high-accuracy cervical cytology classification.
    PLoS One. 2026;21:e0351063.
    PubMed         Abstract available

  88. NEEMA UFOY MUNGU Y, Desreux J, Bianchi E, Junior BL, et al
    Human papillomavirus genotypes and factors associated with major cervical smear abnormalities in a sickle cell endemic area of Kisangani, Democratic Republic of the Congo.
    PLoS One. 2026;21:e0350982.
    PubMed         Abstract available


    Public Health

  89. LUMIA C, Fumagalli S, Martinelli M, Ausili D, et al
    Economic incentives for cervical cancer screening: A qualitative study of healthcare professionals' perspectives.
    Public Health. 2026;257:106385.
    PubMed         Abstract available


    Sci Rep

  90. VEGA C, Medina N, Leon R, Fabelo H, et al
    In-vivo detection of cervical cancer lesions using hyperspectral colposcopy.
    Sci Rep. 2026 Jun 16. doi: 10.1038/s41598-026-58325.
    PubMed         Abstract available

  91. OMAR DI, Althobaiti S, Nabil N, Mohammed SG, et al
    Human papillomavirus vaccination: knowledge, acceptance, and barriers among medical students. An Egyptian multicenter cross sectional study.
    Sci Rep. 2026;16:18528.
    PubMed         Abstract available

  92. SUN Y, Liu P, Ji M, Hao M, et al
    The prognostic value of different HPV infection statuses in cervical cancer.
    Sci Rep. 2026 Jun 14. doi: 10.1038/s41598-026-58010.
    PubMed         Abstract available

  93. HASEGAWA K, Kasuga Y, Ohnishi E, Nakabayashi K, et al
    Vaginal microbiota composition in pregnant women following cervical conization and radical trachelectomy.
    Sci Rep. 2026;16:18798.
    PubMed         Abstract available


    Sex Med

  94. NOV P, Wang D, Tan M, Virak V, et al
    Global, regional, and national burdens of human papillomavirus-associated cervical cancer attributable to sexually acquired human papillomavirus infections among individuals aged 10-54 years from 1990 to 2021: findings from the Global Burden of Diseas
    Sex Med. 2026;14:qfag045.
    PubMed         Abstract available


    Soc Sci Med

  95. DERVEEUW S, Van Landschoot F, Willems S, Vanthomme K, et al
    Navigating racialised healthcare: Intersectional experiences shaping cancer screening among Black women in Belgium.
    Soc Sci Med. 2026;403:119449.
    PubMed         Abstract available


    Surg Oncol

  96. ZHANG MY, Abulajiang Y, Ji C, Yang SL, et al
    Epidemiology and treatment options for cervical cancer patients aged <25?Years based on SEER database and real world research.
    Surg Oncol. 2026;67:102480.
    PubMed         Abstract available


    Transl Cancer Res

  97. GUO L, Song L, Liu X, Zhang B, et al
    Development and validation of prognostic nomograms for patients with cervical cancer and liver metastasis: a SEER-based study.
    Transl Cancer Res. 2026;15:393.
    PubMed         Abstract available

  98. HOU Y, Gao Y, Yan WM
    A bibliometric analysis of global research in cervical cancer radiotherapy (2015-2024): trends, hotspots, and future directions.
    Transl Cancer Res. 2026;15:389.
    PubMed         Abstract available

  99. BURANJIANG G, Xie L, Wang Y, Jin S, et al
    WT1-AS acts as a tumor suppressor in cervical cancer via OSR2-mediated transcriptional activation.
    Transl Cancer Res. 2026;15:386.
    PubMed         Abstract available

  100. WEN X, Zheng W, Zhai T, Wang Q, et al
    Identifying and validating of prognostic genes associated with myeloid cell differentiation in cervical cancer: development of a risk model based on single-cell RNA sequencing combined with bulk RNA sequencing data.
    Transl Cancer Res. 2026;15:390.
    PubMed         Abstract available


    Transl Oncol

  101. XU M, Molina MA, Gomez-Martin C, Dekker MMHS, et al
    Discovery and analytical assessment of urinary miRNA biomarkers for cervical cancer using advanced small RNA sequencing.
    Transl Oncol. 2026;71:102857.
    PubMed         Abstract available


    Urology

  102. POWELL J, Myers JB, Horns JJ, Woodle T, et al
    Treatment-Related Risk of Urologic Adverse Events in Cervical Cancer Survivors.
    Urology. 2026 Jun 14:S0090-4295(26)00370-5. doi: 10.1016/j.urology.2026.
    PubMed         Abstract available


    Virchows Arch

  103. GERYKOVA L, Laco J, Hornychova H, Kamaradova K, et al
    Utility of HoxB13 in differential diagnosis of female genital tract lesions with putative prostatic differentiation.
    Virchows Arch. 2026;488:1293-1302.
    PubMed         Abstract available


    Virus Res

  104. REICH O, Regauer S
    Two target cells for HPV infection at the cervix?
    Virus Res. 2026;369:199754.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum